Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Genetic Engineering Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Shenzhen Neptunus Interlong Bio-Technique Co, Ltd
GeneScience Pharmaceuticals Co, Ltd
Anhui Anke Biotechnology (Group) Co, Ltd
Biotech Pharmaceutical Co, Ltd
3SBio Inc
Shanghai Lansheng Guojian Pharmaceutical Co, Ltd
Tonghua Dongbao Pharmaceutical Co, Ltd
Beijing SL Pharmaceutical Co, Ltd
By Type:
Recombinant Human Insulin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Erythropoietin
Monoclonal Antibody
By Application:
30 Years Old-60 Years Old
＜30 Years Old
＞60 Years Old
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Genetic Engineering Drug Market Overview 2018-2029
-
1.1 China Genetic Engineering Drug Industry Development Overview
-
1.2 China Genetic Engineering Drug Industry Development History
-
1.3 China Genetic Engineering Drug Industry Market Size (2018-2029)
-
1.4 China Genetic Engineering Drug Market Analysis by Type from Production Side
-
1.4.1 China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Insulin (2018-2029)
-
1.4.2 China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Interferon (2018-2029)
-
1.4.3 China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Growth Hormone (2018-2029)
-
1.4.4 China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Erythropoietin (2018-2029)
-
1.4.5 China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibody (2018-2029)
-
1.5 China Genetic Engineering Drug Market Analysis by Application from Consumption End
-
1.5.1 China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate of 30 Years Old-60 Years Old (2018-2029)
-
1.5.2 China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate of ＜30 Years Old (2018-2029)
-
1.5.3 China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate of ＞60 Years Old (2018-2029)
-
1.6 China Genetic Engineering Drug Market Analysis by Region
-
1.6.1 North China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Genetic Engineering Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Genetic Engineering Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Genetic Engineering Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Genetic Engineering Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Genetic Engineering Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Genetic Engineering Drug Industry Development
Chapter 3 Genetic Engineering DrugIndustry Chain Analysis
-
3.1 Genetic Engineering Drug Industry Chain
-
3.2 Genetic Engineering Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Genetic Engineering Drug Market
-
3.3 Genetic Engineering Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Genetic Engineering Drug Market
Chapter 4 China Genetic Engineering Drug Market, by Type
-
4.1 China Genetic Engineering Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Genetic Engineering Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Genetic Engineering Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Insulin
-
4.5.2 China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Interferon
-
4.5.3 China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Growth Hormone
-
4.5.4 China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Erythropoietin
-
4.5.5 China Genetic Engineering Drug Production Volume and Growth Rate of Monoclonal Antibody
Chapter 5 China Genetic Engineering Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Genetic Engineering Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Genetic Engineering Drug Market Size and Growth Rate, by Application
-
5.5.1 China Genetic Engineering Drug Market Size and Growth Rate of 30 Years Old-60 Years Old
-
5.5.2 China Genetic Engineering Drug Market Size and Growth Rate of ＜30 Years Old
-
5.5.3 China Genetic Engineering Drug Market Size and Growth Rate of ＞60 Years Old
Chapter 6 China Genetic Engineering Drug Market, by Region
-
6.1 China Genetic Engineering Drug Production Volume and Production Value, by Region
-
6.2 China Genetic Engineering Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Genetic Engineering Drug Market Analysis
-
7.1 North China Genetic Engineering Drug Market, by Type
-
7.2 North China Genetic Engineering Drug Market, by Application
Chapter 8 Central China Genetic Engineering Drug Market Analysis
-
8.1 Central China Genetic Engineering Drug Market, by Type
-
8.2 Central China Genetic Engineering Drug Market, by Application
Chapter 9 South China Genetic Engineering Drug Market Analysis
-
9.1 South China Genetic Engineering Drug Market, by Type
-
9.2 South China Genetic Engineering Drug Market, by Application
Chapter 10 East China Genetic Engineering Drug Market Analysis
-
10.1 East China Genetic Engineering Drug Market, by Type
-
10.2 East China Genetic Engineering Drug Market, by Application
Chapter 11 Northeast China Genetic Engineering Drug Market Analysis
-
11.1 Northeast China Genetic Engineering Drug Market, by Type
-
11.2 Northeast China Genetic Engineering Drug Market, by Application
Chapter 12 Southwest China Genetic Engineering Drug Market Analysis
-
12.1 Southwest China Genetic Engineering Drug Market, by Type
-
12.2 Southwest China Genetic Engineering Drug Market, by Application
Chapter 13 Northwest China Genetic Engineering Drug Market Analysis
-
13.1 Northwest China Genetic Engineering Drug Market, by Type
-
13.2 Northwest China Genetic Engineering Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Shenzhen Neptunus Interlong Bio-Technique Co, Ltd
-
14.1.1 Shenzhen Neptunus Interlong Bio-Technique Co, Ltd Company Profile
-
14.1.2 Shenzhen Neptunus Interlong Bio-Technique Co, Ltd Genetic Engineering Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 GeneScience Pharmaceuticals Co, Ltd
-
14.2.1 GeneScience Pharmaceuticals Co, Ltd Company Profile
-
14.2.2 GeneScience Pharmaceuticals Co, Ltd Genetic Engineering Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Anhui Anke Biotechnology (Group) Co, Ltd
-
14.3.1 Anhui Anke Biotechnology (Group) Co, Ltd Company Profile
-
14.3.2 Anhui Anke Biotechnology (Group) Co, Ltd Genetic Engineering Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Biotech Pharmaceutical Co, Ltd
-
14.4.1 Biotech Pharmaceutical Co, Ltd Company Profile
-
14.4.2 Biotech Pharmaceutical Co, Ltd Genetic Engineering Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 3SBio Inc
-
14.5.1 3SBio Inc Company Profile
-
14.5.2 3SBio Inc Genetic Engineering Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Shanghai Lansheng Guojian Pharmaceutical Co, Ltd
-
14.6.1 Shanghai Lansheng Guojian Pharmaceutical Co, Ltd Company Profile
-
14.6.2 Shanghai Lansheng Guojian Pharmaceutical Co, Ltd Genetic Engineering Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Tonghua Dongbao Pharmaceutical Co, Ltd
-
14.7.1 Tonghua Dongbao Pharmaceutical Co, Ltd Company Profile
-
14.7.2 Tonghua Dongbao Pharmaceutical Co, Ltd Genetic Engineering Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Beijing SL Pharmaceutical Co, Ltd
-
14.8.1 Beijing SL Pharmaceutical Co, Ltd Company Profile
-
14.8.2 Beijing SL Pharmaceutical Co, Ltd Genetic Engineering Drug Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Genetic Engineering Drug Industry Research Conclusions
-
15.2 Genetic Engineering Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Genetic Engineering Drug Industry Market Size (2018-2029)
-
Figure China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Insulin (2018-2029)
-
Figure China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Interferon (2018-2029)
-
Figure China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Growth Hormone (2018-2029)
-
Figure China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Recombinant Human Erythropoietin (2018-2029)
-
Figure China Genetic Engineering Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibody (2018-2029)
-
Figure China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate of 30 Years Old-60 Years Old (2018-2029)
-
Figure China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate of ＜30 Years Old (2018-2029)
-
Figure China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate of ＞60 Years Old (2018-2029)
-
Figure North China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Genetic Engineering Drug Market Size and Growth Rate from 2018-2029
-
Figure Genetic Engineering Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Genetic Engineering Drug Market Share by Type in 2018
-
Figure China Genetic Engineering Drug Market Share by Type in 2023
-
Figure China Genetic Engineering Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Insulin (2018-2023)
-
Figure China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Interferon (2018-2023)
-
Figure China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Growth Hormone (2018-2023)
-
Figure China Genetic Engineering Drug Production Volume and Growth Rate of Recombinant Human Erythropoietin (2018-2023)
-
Figure China Genetic Engineering Drug Production Volume and Growth Rate of Monoclonal Antibody (2018-2023)
-
Figure China Genetic Engineering Drug Market Share by Application in 2018
-
Figure China Genetic Engineering Drug Market Share by Application in 2023
-
Figure China Genetic Engineering Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Genetic Engineering Drug Market Size and Growth Rate of 30 Years Old-60 Years Old (2018-2023)
-
Figure China Genetic Engineering Drug Market Size and Growth Rate of ＜30 Years Old (2018-2023)
-
Figure China Genetic Engineering Drug Market Size and Growth Rate of ＞60 Years Old (2018-2023)
-
Table China Genetic Engineering Drug Production Volume by Region (2018-2023)
-
Table China Genetic Engineering Drug Production Volume Share by Region (2018-2023)
-
Figure China Genetic Engineering Drug Production Volume Share by Region (2018-2023)
-
Table China Genetic Engineering Drug Production Value by Region (2018-2023)
-
Table China Genetic Engineering Drug Production Value Share by Region (2018-2023)
-
Figure China Genetic Engineering Drug Production Value Share by Region (2018-2023)
-
Table China Genetic Engineering Drug Sales Volume by Region (2018-2023)
-
Table China Genetic Engineering Drug Sales Volume Share by Region (2018-2023)
-
Figure China Genetic Engineering Drug Sales Volume Share by Region (2018-2023)
-
Table China Genetic Engineering Drug Sales Value by Region (2018-2023)
-
Table China Genetic Engineering Drug Sales Value Share by Region (2018-2023)
-
Figure China Genetic Engineering Drug Sales Value Share by Region (2018-2023)
-
Table North China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table North China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure North China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table North China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table North China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table Central China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table Central China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table Central China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table South China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table South China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure South China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table South China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table South China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table East China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table East China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure East China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table East China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table East China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table Northeast China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table Southwest China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Genetic Engineering Drug Production Volume by Type (2018-2023)
-
Table Northwest China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Genetic Engineering Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Genetic Engineering Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Genetic Engineering Drug Sales Volume Share by Application (2018-2023)
-
Table Shenzhen Neptunus Interlong Bio-Technique Co, Ltd Company Profile
-
Table Shenzhen Neptunus Interlong Bio-Technique Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table GeneScience Pharmaceuticals Co, Ltd Company Profile
-
Table GeneScience Pharmaceuticals Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table Anhui Anke Biotechnology (Group) Co, Ltd Company Profile
-
Table Anhui Anke Biotechnology (Group) Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table Biotech Pharmaceutical Co, Ltd Company Profile
-
Table Biotech Pharmaceutical Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table 3SBio Inc Company Profile
-
Table 3SBio Inc Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table Shanghai Lansheng Guojian Pharmaceutical Co, Ltd Company Profile
-
Table Shanghai Lansheng Guojian Pharmaceutical Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table Tonghua Dongbao Pharmaceutical Co, Ltd Company Profile
-
Table Tonghua Dongbao Pharmaceutical Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
Table Beijing SL Pharmaceutical Co, Ltd Company Profile
-
Table Beijing SL Pharmaceutical Co, Ltd Genetic Engineering Drug Revenue, Price and Gross (2018-2023)
-
